These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 18754087)
1. [Therapy of familial hypercholesterolemia with or without ezetimibe]. Berthold HK; Nitschmann S Internist (Berl); 2008 Oct; 49(10):1274-6. PubMed ID: 18754087 [No Abstract] [Full Text] [Related]
2. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Kastelein JJ; Akdim F; Stroes ES; Zwinderman AH; Bots ML; Stalenhoef AF; Visseren FL; Sijbrands EJ; Trip MD; Stein EA; Gaudet D; Duivenvoorden R; Veltri EP; Marais AD; de Groot E; N Engl J Med; 2008 Apr; 358(14):1431-43. PubMed ID: 18376000 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615 [No Abstract] [Full Text] [Related]
4. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Eichhorn EJ N Engl J Med; 2008 Jul; 359(5):529-30; author reply 532. PubMed ID: 18677795 [No Abstract] [Full Text] [Related]
5. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Steinberg D N Engl J Med; 2008 Jul; 359(5):529; author reply 532. PubMed ID: 18669434 [No Abstract] [Full Text] [Related]
6. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Connor WE N Engl J Med; 2008 Jul; 359(5):530; author reply 532-3. PubMed ID: 18677797 [No Abstract] [Full Text] [Related]
7. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe. Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996 [No Abstract] [Full Text] [Related]
8. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733 [TBL] [Abstract][Full Text] [Related]
9. Is there a problem with ezetimibe or just ENHANCEd hype? Whayne TF Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445 [No Abstract] [Full Text] [Related]
10. Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial. Jakulj L; Vissers MN; Groen AK; Hutten BA; Lutjohann D; Veltri EP; Kastelein JJ J Lipid Res; 2010 Apr; 51(4):755-62. PubMed ID: 19828909 [TBL] [Abstract][Full Text] [Related]
11. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Diamond GA; Kaul S N Engl J Med; 2008 Jul; 359(5):530; author reply 532. PubMed ID: 18677796 [No Abstract] [Full Text] [Related]
13. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe? Brown BG; Taylor AJ N Engl J Med; 2008 Apr; 358(14):1504-7. PubMed ID: 18376002 [No Abstract] [Full Text] [Related]
14. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial. Kastelein JJ; Sager PT; de Groot E; Veltri E Am Heart J; 2005 Feb; 149(2):234-9. PubMed ID: 15846260 [TBL] [Abstract][Full Text] [Related]
15. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Blake JA N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677798 [No Abstract] [Full Text] [Related]
16. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Kaye T N Engl J Med; 2008 Jul; 359(5):531-2; author reply 532-3. PubMed ID: 18677800 [No Abstract] [Full Text] [Related]
17. ENHANCE: food for the ostriches. Jackson G Int J Clin Pract; 2008 May; 62(5):667-8. PubMed ID: 18412925 [No Abstract] [Full Text] [Related]
18. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia. Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR; Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688 [TBL] [Abstract][Full Text] [Related]
19. Lipid-lowering study raises issues of therapy's value. Thompson CA Am J Health Syst Pharm; 2008 Apr; 65(7):594-5. PubMed ID: 18359962 [No Abstract] [Full Text] [Related]
20. [On the current debate on lowering LDL cholesterol with ezetimibe]. Breuer HW Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008 [No Abstract] [Full Text] [Related] [Next] [New Search]